Abstract
Systemic sclerosis (SSc) is a multi-systemic fibrotic disorder with worldwide distribution and high morbidity and mortality. Characteristic features of this disease are widespread vasculopathy, inflammation, autoimmunity, and fibrosis. The better clinical outcome in recent years is mainly due to better management of organ complications. To date, there is no approved specific therapy to prevent or slow down the overall progression of the disease. So far, conventional disease-modifying antirheumatic drugs (DMARDs) have had no major impact on the disease course and have not prolonged survival. Based on recent studies of molecular pathomechanisms and various animal models, key molecules of fibrogenesis and vasculopathy in SSc could be identified. Therefore, to date, we have to reconsider and redefine the objectives of our treatment strategies. In this article, we discuss current and future therapeutic concepts as well as the objectives of new treatment strategies and of the evaluation of diagnostic tools with respect to pulmonary arterial hypertension, lung fibrosis and skin/systemic fibrosis.
References
Apr 1, 1986·Arthritis and Rheumatism·A M StupiT A Medsger
Sep 1, 1994·Arthritis and Rheumatism·V D SteenT A Medsger
Sep 1, 1994·Arthritis and Rheumatism·V D SteenT A Medsger
Feb 12, 2004·Arthritis and Rheumatism·Maureen D MayesM E Csuka
Jul 14, 2004·Chest·Vallerie V McLaughlinUNKNOWN American College of Chest Physicians
Dec 14, 2004·European Heart Journal·Nazzareno GalièUNKNOWN Task Force
Oct 18, 2005·Clinical Rheumatology·O NadashkevichW Kovalenko
Dec 2, 2005·Arthritis and Rheumatism·Eric HachullaMarc Humbert
Dec 17, 2005·Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases·Virginia D Steen
Jun 23, 2006·The New England Journal of Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Jun 24, 2006·Annals of the Rheumatic Diseases·C P DentonC M Black
Nov 30, 2006·Arthritis and Rheumatism·Lionel SchachnaAllan C Gelber
Jan 27, 2007·Rheumatology·F VerrecchiaD Farge
Mar 3, 2007·Annals of the Rheumatic Diseases·Virginia D Steen, Thomas A Medsger
Mar 3, 2007·The Journal of Clinical Investigation·John Varga, David Abraham
Jun 1, 2007·Dermatologic Therapy·Sandra E Bendeck, Heidi T Jacobe
Jun 30, 2007·Arthritis and Rheumatism·Lynne ShandChristopher P Denton
Aug 25, 2007·American Journal of Respiratory and Critical Care Medicine·Donald P TashkinUNKNOWN Scleroderma Lung Study Research Group
Oct 27, 2007·Seminars in Hematology·Jakob Passweg, Alan Tyndall
Feb 19, 2008·Rheumatology·D McGonagleS Thomas
Mar 29, 2008·American Journal of Respiratory and Critical Care Medicine·Nicole S L GohAthol U Wells
Apr 9, 2008·Rheumatology·D McGonagleP Emery
Apr 29, 2008·Arthritis and Rheumatism·Peter A MerkelUNKNOWN Scleroderma Clinical Trials Consortium
Jun 3, 2008·Arthritis and Rheumatism·Oliver DistlerUNKNOWN EPOSS-Omeract Group
Jun 24, 2008·Lancet·N GalièG Simonneau
Jul 16, 2008·Chest·Raymond L BenzaRobert Naeije
Aug 1, 2008·Arthritis and Rheumatism·Jörg H W DistlerOliver Distler
Aug 1, 2008·Arthritis and Rheumatism·Jörg H W DistlerOliver Distler